{"id":75627,"date":"2012-12-13T13:26:50","date_gmt":"2012-12-13T13:26:50","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=75627"},"modified":"2012-12-13T13:26:50","modified_gmt":"2012-12-13T13:26:50","slug":"labormed-la-un-pas-de-a-intra-in-portofoliul-unui-grup-american","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=75627","title":{"rendered":"Labormed, la un pas de a intra \u00een portofoliul unui grup american"},"content":{"rendered":"<p>Compania american\u0103 de medicamente generice Alvogen, prezent\u0103 de c\u00e2\u0163iva ani \u015fi pe pia\u0163a din Rom\u00e2nia, ar fi \u00een discu\u0163ii pentru produc\u0103torul rom\u00e2n, conform acelora\u015fi surse. Tranzac\u0163ia este destul de complicat\u0103 av\u00e2nd \u00een vedere c\u0103 fondul de investi\u0163ii Advent ar fi cedat ac\u0163ionariatul, iar un grup de b\u0103nci \u00eencearc\u0103 s\u0103-\u015fi recupereze o parte din creditele acordate. \u00cen achizi\u0163ia Labormed \u00een 2008 plus celelalte prelu\u0103ri (Ozone) s-au investit peste 120 mil. euro de c\u0103tre Advent \u015fi un grup de b\u0103nci care au creditat fondul. Contactat de ZF, Adrian Stroilescu, CEO al Labormed din august, nu a dorit s\u0103 comenteze pe marginea informa\u0163i\u00adilor legate de o eventual\u0103 v\u00e2nzare. Reprezentan\u0163ii Alvogen nu au putut fi contacta\u0163i p\u00e2n\u0103 la \u00eenchiderea edi\u0163iei.<\/p>\n<p><a href=\"http:\/\/www.zfcorporate.ro\/pharma\/discutii-in-jurul-labormed-producatorul-la-un-pas-de-a-intra-in-portofoliul-unui-grup-american-10389129\"><strong>Citi\u0163i articolul integral pe www.zfcorporate.ro<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mai mul\u0163i investitori sunt interesa\u0163i de produc\u0103torul de medicamente Labormed, una dintre pu\u0163inele \u0163inte de preluare de pe pia\u0163a farmaceutic\u0103 local\u0103, iar o eventual\u0103 tranzac\u0163ie s-ar ridica la 25-30 mil. euro, potrivit unor surse din industria de medicamente.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[8088,11060,474,7593,400],"class_list":["post-75627","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-farma","tag-generice","tag-industrie","tag-labormed","tag-tranzactie"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/75627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=75627"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/75627\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=75627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=75627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=75627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}